title: Use of the LHRH analogue zoladex depot alone and in combination with cyproterone acetate in the treatment of advanced prostatic cancer.
authors.affiliation: Institute of Urological Pathology, University La Sapienza, Rome, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Di Silverio
authors.forename: M
authors.initials: M
authors.lastname: Serio
authors.forename: A
authors.initials: A
authors.lastname: Costantini
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017373:Cyproterone Acetate / Q000008:administration & dosage; D018450:Disease Progression; D017273:Goserelin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D018931:Antineoplastic Agents, Hormonal; D017273:Goserelin; D017373:Cyproterone Acetate